Brief: ExpreS2ion: Successful Manufacturing Of cVLP COVID-19 Vaccine

ExpreS2ion Biotech Holding AB

16/11/2020 07:35

Nov 16 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION ANNOUNCES SUCCESSFUL MANUFACTURING OF THE CVLP
COVID-19 VACCINE AND FURTHER POSITIVE UPDATES
    * PROJECT REMAINS ON TRACK FOR PRESENTING INITIAL CLINICAL
PHASE
I/IIA RESULTS IN Q1 2021
    * SUCCESSFUL RESULTS OF PFIZER PHASE III STUDY DEMONSTRATE
HIGH
LIKELIHOOD OF SUCCESS FOR CVLP COVID-19 VACCINE WHEN COMPARING
PRECLINICAL DATA FROM TWO PROGRAMS
    * CVLP TECHNOLOGY AND MANUFACTURING PROCESSES USED ARE
PERFECTLY
SUITED FOR RAPIDLY MANUFACTURING NEW VACCINES IN RESPONSE TO
POTENTIAL COVID-19 MUTATIONS

Source text for Eikon:  ID:nWkrbvQYff 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))